A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Pro Medicus Limited, a healthcare informatics company, provides medical imaging software and services to hospitals, imaging centers, and health care groups in Australia, Europe, and North America. The company offers Visage RIS, an enterprise-class radiology information system for patient registration, billing, scheduling, typing, HL7 integration, financial reporting, picture archive and communication system (PACS) integration, digital dictation, and voice recognition integration; and Visage RIS/PACS, a solution for imaging needs of organizations. It also provides Visage 7 Enterprise Imaging Platform, a healthcare imaging software for radiologists, physicians, and clinicians for access and visualization capability comprising rapidly viewing 2-D, 3-D, and 4-D medical images, as well as PACS, digital imaging software, training, installation, and professional services and support products; and Visage Ease, a native mobile application for access to medical imaging results stored on a Visage 7 server from iOS devices, including iPad, iPhone, and iTouch. In addition, the company offers Visage Ease Pro for interpreting diagnostic imaging studies; and Promedicus.net, an e-health offering. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.
Financial Summary
| Share Statistics | PMDIY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $12,968.6 | $225.4 | 81% |
|
| Shares Out (Mil) | 72.4 | 47.8 | 56% |
|
| Institutional Ownership | 16.9% | 79.3% | 8% |
|
| Float (Mil) | 53.3 | 39.7 | 48% |
|
| Beta | 0.57 | 1.27 | 33% |
|
| Avg Daily Volume (000s) | 5 | 277 | 14% |
|
| Price Change (52-week) |
na | 47.3% | na |
|
| Growth | PMDIY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 28.8% | 11.8% | 89% |
|
| Net Income (5yr) | 51.4% | 2.7% | 94% |
|
| EPS (5yr) | 51.3% | 15.5% | 93 |
|
| Dividends (5yr) | 33.5% | 0.0% | 68% |
|
| Cash Flow (5yr) | 108.1% | (15.8%) | 99% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | PMDIY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $181 | $202 | 31% |
|
| Net Income (TTM) (Mil) | $184 | ($9) | 67% |
|
| EPS (TTM) | $1.757 | ($0.600) | 69% |
|
| Operating Cash Flow (TTM) (Mil) | $88 | ($1) | 51% |
|
| Net Cash Flow (TTM) (Mil) | $27 | $3 | 65% |
|
| Long-Term Debt (Q1) (Mil) | $1 | $18 | 17% |
|
| Enterprise Value (Q1) (Mil) | $14,198 | $171 | 79% |
|
| Valuation | PMDIY | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 1.27 | na |
|
| P/E | na | 41.4 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 2.6 | na |
|
| Ratios | PMDIY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 99.8% | 61.6% | 96% |
|
| Net Margin | 101.4% | (24.1%) | 99% |
|
| ROA | 57.0% | (21.8%) | 99% |
|
| ROE | 76.4% | (6.7%) | 95% |
|
| Liabilities to Assets | 26.1% | 32.1% | 18% |
|
| F-Score | na | 4 | na |
|
Pro Medicus Limited did not pass any screens on 9/3/2026.
